|Videos|June 11, 2013
Raising Patient Cost Share for Specialty Medications
Debbie Stern, RPh, president of Rxperts, explains why a high entry cost for a specialty drug may dissuade a patient from filling and staying adherent to his or her prescription.
Advertisement
Debbie Stern, RPh, president of Rxperts, explains why a high entry cost for a specialty drug may dissuade a patient from filling and staying adherent to his or her prescription. Video from the 2013 Armada Specialty Pharmacy Summit in Las Vegas, Nevada.
For more videos from this conference, vist our
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Should Know About Long COVID and Brain Health
2
Expert: Why Cutting Alcohol May Enhance GLP-1 Outcomes in Patients With Obesity and Diabetes Risk
3
Depression May Be an Early Manifestation of Neurodegenerative Changes Leading to Movement Disorders
4
Early-Line Immunotherapy Challenges the Role of Transplant in Multiple Myeloma
5